Adiponectin
Showing 51 - 75 of 1,676
Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Birmingham, Saint Louis (Glycemic
Not yet recruiting
- Relapsing Remitting Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- Glycemic load
- +2 more
-
Birmingham, Alabama
- +1 more
Jan 4, 2023
Elderly With Type 2 Diabetes Trial in Pathum Wan (Nordic walking in water, No exercise intervention)
Recruiting
- Elderly With Type 2 Diabetes
- Nordic walking in water
- No exercise intervention
-
Pathum Wan, Bangkok, ThailandFaculty of Sports Science, Chulalongkorn University
Nov 29, 2022
Obesity, Metabolic Syndrome, Metabolic Disorder Trial in Seville (Oral lipid emulsions)
Not yet recruiting
- Obesity
- +4 more
- Oral lipid emulsions
-
Seville, SpainUniversity of Seville
Sep 19, 2023
Obesity, Life Style, Healthy, Follow-up Trial in Odense (Lifestyle intervention Dietary advise and/or advise on physical
Not yet recruiting
- Obesity
- +4 more
- Lifestyle intervention Dietary advise and/or advise on physical activity
-
Odense, DenmarkSteno Diabetes Center Odense
Mar 21, 2023
Insulin Resistance Trial in Christchurch (TLC-3595 Dose 1, TLC-3595 Dose 2, Placebo)
Not yet recruiting
- Insulin Resistance
- TLC-3595 Dose 1
- +2 more
-
Christchurch, New ZealandNew Zealand Clinical Research
Dec 16, 2022
Nonalcoholic Fatty Liver Disease, Type 2 Diabetes Trial in Damanhur (Dapagliflozin 10mg Tab, Placebo)
Recruiting
- Nonalcoholic Fatty Liver Disease
- Type 2 Diabetes
- Dapagliflozin 10mg Tab
- Placebo
-
Damanhūr, Elbehairah, EgyptRehab Hussein Werida
Aug 11, 2022
Obesity, Metabolic Syndrome, Metabolic Disorder Trial in Seville (Mediterranean diet supplement with 20 g / day of hemp
Completed
- Obesity
- +4 more
- Mediterranean diet supplement with 20 g / day of hemp protein.
-
Seville, SpainUniversity of Seville
Nov 8, 2023
Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)
Completed
- Healthy Subjects
- +2 more
- HEC88473 injection
- Placebo
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jul 14, 2023
Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)
Recruiting
- Metabolic Associated Fatty Liver Disease
- LUDLEV®300 mg/46.2 mg
- Placebo
-
Mexico, Veracruz, MexicoAna Delfina Cano Contreras
Jun 12, 2023
Cardiometabolic Syndrome, Obesity Trial in New York (Intermittent Short Sleep (ISS), Social Jetlag (SJL), Sustained Adequate
Recruiting
- Cardiometabolic Syndrome
- Obesity
- Intermittent Short Sleep (ISS)
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
May 31, 2023
Aging Trial in Orlando (Abdominal subcutaneous adipose tissue biopsy)
Active, not recruiting
- Aging
- Abdominal subcutaneous adipose tissue biopsy
-
Orlando, FloridaAdventHealth Translational Research Institute
Aug 16, 2023
Overweight and Obesity Trial in Shanghai, Jinhua (Study product A (Wonderlab wonder4shape), Study product B (Wonderlab
Recruiting
- Overweight and Obesity
- Study product A (Wonderlab wonder4shape)
- +2 more
-
Shanghai, Shanghai, China
- +1 more
Sep 3, 2023
Cardiac Disease, Cardiac Rehabilitation Trial (Thermotherapy)
Not yet recruiting
- Cardiac Disease
- Cardiac Rehabilitation
- Thermotherapy
- (no location specified)
Feb 13, 2023
Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)
Not yet recruiting
- Breast Cancer
- +2 more
- Dapagliflozin 10mg
-
New Haven, ConnecticutYale Cancer Center Smilow Cancer Hospital
Aug 3, 2023
Alcoholic Hepatitis Trial in New Delhi (Saturated Fat- Desi Ghee (Clarified Butter), Soyabean Oil)
Completed
- Alcoholic Hepatitis
- Saturated Fat- Desi Ghee (Clarified Butter)
- Soyabean Oil
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Mar 29, 2022
Coronary Artery Disease Trial in Ankara (Omega-3 fatty acid supplementation)
Completed
- Coronary Artery Disease
- Omega-3 fatty acid supplementation
-
Ankara, TurkeyGazi University Training and Research Hospital
Dec 14, 2022
Body Fat Disorder Trial in New Delhi (Oral Dyglomera)
Completed
- Body Fat Disorder
- Oral Dyglomera
-
New Delhi, Patparganj, IndiaMax Super Specialty Hospital
Aug 1, 2022
Diabetes, Metabolic Disease Trial in Taipei (Pumpkin seed extract (Low dose), Pumpkin seed extract (High dose), Placebo)
Not yet recruiting
- Diabetes
- Metabolic Disease
- Pumpkin seed extract (Low dose)
- +2 more
-
Taipei, TaiwanWanFang Hospital
Feb 12, 2023
Heart Failure, Type 2 Diabetes, Glucose Intolerance Trial in Montreal (Eplerenone, Spironolactone)
Completed
- Heart Failure
- +2 more
-
Montreal, Quebec, CanadaMontreal Heart Institute
Oct 5, 2022
Desire to Exercise, Exercise Training, Physical Exertion Trial in Iowa City (Organic Guayusa Extract, Placebo)
Completed
- Desire to Exercise
- +2 more
- Organic Guayusa Extract
- Placebo
-
Iowa City, IowaIntegrative Laboratory of Applied Physiology and Lifestyle Medic
Apr 6, 2023
Obesity, Infant Obesity, Mother-Child Relations Trial in Fort Defiance, Whiteriver, Shiprock (Family Spirit Nurture (FSN),
Active, not recruiting
- Obesity
- +7 more
- Family Spirit Nurture (FSN)
- +2 more
-
Fort Defiance, Arizona
- +2 more
Jan 5, 2023
Metabolism, Breastmilk, and Microbiome
Active, not recruiting
- Obesity
- Diabetes, Gestational
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 1, 2022
Colon Cancer, Rectal Cancer, Cancer Survivor Trial in Seattle (Dietary Intervention (resistant starch), Dietary Intervention
Terminated
- Colon Cancer
- +12 more
- Dietary Intervention (resistant starch)
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 9, 2022
Breast Milk Collection, Overweight and Obesity Trial in Trondheim (Moderate intensity exercise, High intensity exercise)
Recruiting
- Breast Milk Collection
- Overweight and Obesity
- Moderate intensity exercise
- High intensity exercise
-
Trondheim, NorwayDepartment of circulation and medical imaging , NTNU
Mar 1, 2023